| A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies (NCT05032040) | Xencor, Inc. | 2022-07-21 |
| Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer (NCT05332483) | Sunnybrook Health Sciences Centre | 2022-07-05 |
| Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 (NCT05383482) | Laekna Limited | 2022-07-01 |
| Comprehensive Outcomes for After Cancer Health (NCT05349227) | Pack Health | 2022-06-23 |
| Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma (NCT05364905) | ARCAGY/ GINECO GROUP | 2022-05-09 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer (NCT05807672) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2022-04-23 |
| Michigan Genetic Hereditary Testing (MiGHT) (NCT05162846) | University of Michigan Rogel Cancer Center | 2022-04-21 |
| Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line (NCT05201547) | ARCAGY/ GINECO GROUP | 2022-04-15 |
| (VELA) Study of BLU-222 in Advanced Solid Tumors (NCT05252416) | Blueprint Medicines Corporation | 2022-04-07 |
| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors (NCT05194735) | Alaunos Therapeutics | 2022-04-04 |
| Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy (NCT04997096) | Dana-Farber Cancer Institute | 2022-04-02 |
| Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer (NCT05263492) | Virginia Commonwealth University | 2022-04-01 |
| Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients (NCT05320757) | The University of Hong Kong | 2022-04-01 |
| A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451) | Lyell Immunopharma, Inc. | 2022-03-29 |
| Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study (NCT05242276) | Instituto de Investigacion Sanitaria La Fe | 2022-03-20 |
| Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (NCT05169437) | Tempus AI | 2022-03-15 |
| Host DNA Methylation for Endometrial Cancer Screening (NCT05290415) | Lei Li | 2022-03-13 |
| DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening (NCT05290922) | Lei Li | 2022-03-12 |
| Evaluation of MCM5 in Postmenopausal Bleeding Patients (NCT05287048) | Arquer Diagnostics Ltd | 2022-03-01 |
| Single cEll pRofiling PErsistaNce To ImmuNothErapy (NCT06680739) | Vall d'Hebron Institute of Oncology | 2022-03-01 |
| Study of Copanlisib and Ketogenic Diet (NCT04750941) | Columbia University | 2022-02-10 |
| Optimising Cardiovascular Health in Endometrial Cancer Survivors (NCT05216913) | University of Manchester | 2022-02-09 |
| Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer (NCT04845828) | Asan Medical Center | 2022-01-26 |
| A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors (NCT05143970) | Institut Paoli-Calmettes | 2022-01-21 |
| Predictors of Node Positivity in Endometrial Cancer (NCT05793333) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-01-10 |
| Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients (NCT05056259) | Assiut University | 2022-01-01 |
| Sexual Health Integration in Treatment of Gynecological Oncology (NCT06958068) | Medical University of Silesia | 2022-01-01 |
| Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers (NCT04611139) | HonorHealth Research Institute | 2021-12-31 |
| A Study of DeTIL-0255 in Adults With Advanced Malignancies (NCT05107739) | Nurix Therapeutics, Inc. | 2021-12-22 |
| Registry Platform Ovarian and Endometrial Cancer (NCT05129969) | iOMEDICO AG | 2021-11-25 |
| First in Human Study of TORL-1-23 in Participants With Advanced Cancer (NCT05103683) | TORL Biotherapeutics, LLC | 2021-11-17 |
| Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (NCT05255653) | Leiden University Medical Center | 2021-11-11 |
| A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours (NCT05057013) | Cancer Research UK | 2021-11-10 |
| Comparison of Nodal Staging in Endometrial Cancer (NCT04970368) | Frederick R. Ueland, M.D. | 2021-11-05 |
| Asian Multicenter Prospective Study of ctDNA Sequencing (NCT05099978) | National Cancer Center, Japan | 2021-11-01 |
| Avera Cancer Sequencing and Analytics Protocol (ASAP) (NCT05142033) | Avera McKennan Hospital & University Health Center | 2021-11-01 |
| A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer (NCT04486352) | Alliance Foundation Trials, LLC. | 2021-10-20 |
| A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies (NCT05123482) | AstraZeneca | 2021-10-18 |
| Time Restricted Eating (TRE) Among Endometrial Cancer Patients (NCT04783467) | University of Utah | 2021-10-07 |
| Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer (NCT05387460) | Tongji Hospital | 2021-10-01 |
| HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors (NCT05124743) | Alaunos Therapeutics | 2021-09-24 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282) | Elucida Oncology | 2021-09-13 |
| Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer (NCT04995731) | Assiut University | 2021-09-01 |
| Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence (NCT04930159) | University of Washington | 2021-09-01 |
| Adipocytokines in Endometrial Cancer (NCT05018195) | National Taiwan University Hospital | 2021-09-01 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors (NCT04780217) | ImmVira Pharma Co. Ltd | 2021-08-10 |
| A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors (NCT04577963) | Hutchmed | 2021-08-09 |
| Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer (NCT05051722) | Mayo Clinic | 2021-08-03 |
| Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II (NCT04890912) | Sunnybrook Health Sciences Centre | 2021-07-15 |
| Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer (NCT05191212) | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | 2021-07-13 |
| Adjuvant Radiotherapy in Patients With Early Endometrial Cancer (NCT04956601) | Peking University Third Hospital | 2021-07-01 |
| [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer (NCT04972682) | Moscow City Oncology Hospital No. 62 | 2021-07-01 |
| Study of XB002 in Subjects With Solid Tumors (JEWEL-101) (NCT04925284) | Exelixis | 2021-06-07 |
| Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer (NCT04586959) | Anthony Costales, MD | 2021-05-21 |
| Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study) (NCT04945187) | Rigshospitalet, Denmark | 2021-05-17 |
| Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (NCT04008563) | University Health Network, Toronto | 2021-05-14 |
| Endometrial Cancer International Database (NCT04787159) | Assiut University | 2021-05-01 |
| Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. (NCT05610501) | Universitaire Ziekenhuizen KU Leuven | 2021-05-01 |
| Adipocytokines in Endometrial Cancer (NCT04697264) | University of Surrey | 2021-04-12 |
| Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery (NCT04774419) | Memorial Sloan Kettering Cancer Center | 2021-04-02 |
| Analysis of miRNA Expression in Endometrial Cancer (NCT04845425) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-04-01 |
| The LYSA (Linking You to Support and Advice) Trial (NCT05035173) | University College Cork | 2021-03-13 |
| TH1902 in Patients With Advanced Solid Tumors (NCT04706962) | Theratechnologies | 2021-03-04 |
| Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer (NCT04458402) | Teresa Meier | 2021-02-04 |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging (NCT04514692) | Stanford University | 2021-02-01 |
| A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors (NCT04657068) | Artios Pharma Ltd | 2021-01-27 |
| Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. (NCT04463771) | Incyte Corporation | 2021-01-26 |
| Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer (NCT05931445) | Comprehensive Support Project for Oncology Research | 2021-01-26 |
| Prehabilitation in Gynaecological Cancer Patients (NCT04789694) | Charles University, Czech Republic | 2021-01-25 |
| Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer (NCT04511026) | Stanford University | 2021-01-20 |
| Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer (NCT04683653) | University of Chicago | 2021-01-15 |
| The Role of Endometrial Blood Flow in Endometrial Cancer (NCT05034991) | Far Eastern Memorial Hospital | 2021-01-05 |
| Circulating Tumor DNA Study in Patients With Endometrial Cancer (NCT05955079) | Assistance Publique - Hôpitaux de Paris | 2021-01-01 |
| Tracers for Endometrial Cancer Sentinel Node Labeling (NCT04665544) | University Medical Centre Maribor | 2021-01-01 |
| Detection of Tumor DNA Through Cervical Smear and Liquid Biopsy in Endometrial Cancer Patients and Evaluation of Prognostic and Predictive Values of Tumor DNA Assay (NCT05504161) | Yonsei University | 2020-12-30 |
| Cell-free DNA Methylation for Endometrial Cancer (NCT04651738) | Lei Li | 2020-12-18 |
| Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity (NCT04631731) | Western Sydney Local Health District | 2020-12-15 |
| A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab (NCT04590326) | Regeneron Pharmaceuticals | 2020-12-08 |
| Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia (NCT04362046) | Vancouver Coastal Health Research Institute | 2020-11-15 |
| Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (NCT04644068) | AstraZeneca | 2020-11-12 |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers (NCT04570553) | WellSpan Health | 2020-10-15 |
| Sentinel Node in Endometrial Cancer (NCT04492995) | Judit Pich Martínez | 2020-10-05 |
| Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer (NCT04569773) | Memorial Sloan Kettering Cancer Center | 2020-09-23 |
| A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors (NCT04073680) | Petra Pharma | 2020-09-01 |
| Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma (NCT04444193) | Shanghai First Maternity and Infant Hospital | 2020-08-31 |
| Tumor Grade Determines PD-1/PDL-1 Expression (NCT04528940) | RWJ Barnabas Health at Jersey City Medical Center | 2020-08-25 |
| Mindfulness in Endometrial and Cervical Cancer (NCT04512144) | St. Louis University | 2020-07-25 |
| Gyn Onc Prehab Study (NCT04298827) | St. Louis University | 2020-07-21 |
| A Novel Tapered Applicator for Vaginal Vault Brachytherapy (NCT04318340) | Yale University | 2020-07-16 |
| Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer (NCT03832361) | Alessandro Santin | 2020-07-15 |
| Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer (NCT04705649) | British Columbia Cancer Agency | 2020-07-14 |
| Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer (NCT05220033) | Rutgers, The State University of New Jersey | 2020-07-14 |
| De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (NCT04386993) | Washington University School of Medicine | 2020-07-07 |
| Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation (NCT04489706) | Ruijin Hospital | 2020-06-28 |
| Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. (NCT04456972) | Poitiers University Hospital | 2020-06-19 |
| SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma (NCT04205630) | Byondis B.V. | 2020-05-28 |